German firms collaborate on diagnostic nano-sensors:
This article was originally published in Clinica
German nanotechnology firms Nanosolutions and Capsulution NanoScience are to jointly develop a new generation of multifunctional nano-sensors for IVD applications. Their research will include the development of hollow capsule-sensors, whereby the nanometer-thin wall will be equipped with various functional nano-particles. The companies' long-term goal is to combine diagnostics and therapy in order to develop "personalised" medicines. Nanosolutions of Hamburg is currently establishing novel manufacturing processes in nanotechnology that can offer tailor-made customer-specific solutions. Capsulution, based in Berlin, is a developer of nano- and micro-sized capsules designed to function according to its intended application.
You may also be interested in...
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.
After an eleventh-hour win last year that saw Congress repeal the medical device excise tax, AdvaMed is going more global. CEO Scott Whitaker sat down with Medtech Insight for a lengthy chat about what the lobby group will focus on in 2020, including reimbursement challenges, the upcoming medical device user-fee negotiations, and negotiations with governments that are key to the industry ecosystem.